BPC-157 CAPSULES
BPC-157 in capsule form, 500mcg per capsule. This synthetic pentadecapeptide comes from a protective gastric protein sequence, and its research record covers tissue repair signaling, gastric mucosal protection, and angiogenesis.
Purity >99.95%Form CapsuleNo Endotoxins
Notify me when back in stock
Peer-Reviewed Literature
Related Studies
Peer-Reviewed Literature
Related Studies
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
HSS Journal
Analysis of 36 studies (1993–2024) found BPC-157 enhanced growth hormone receptor expression, angiogenic pathways, and reduced inflammatory cytokines with improved biomechanical outcomes in musculoskeletal injuries.
Gastric Pentadecapeptide Body Protection Compound BPC 157 and Its Role in Accelerating Musculoskeletal Soft Tissue Healing
Cell and Tissue Research
Comprehensive review concluding that all BPC-157 studies demonstrate consistently positive and prompt healing effects for various traumatic and systemic soft tissue injuries including tendons, ligaments, and skeletal muscle.
The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration
Journal of Applied Physiology
BPC 157 significantly accelerated tendon explant outgrowth, increased cell survival under oxidative stress, and markedly increased in vitro migration of tendon fibroblasts in a dose-dependent manner.
Gastric Pentadecapeptide BPC 157 Accelerates Healing of Transected Rat Achilles Tendon and In Vitro Stimulates Tendocytes Growth
Journal of Orthopaedic Research
BPC 157 improved tendon healing biomechanically (increased load-to-failure and elasticity), functionally, and microscopically — achieving superior fibroblast formation and collagen deposition.
BPC 157 Rescued NSAID-Cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
Current Pharmaceutical Design
BPC-157 counteracted NSAID-induced intestinal damage by stabilizing intestinal permeability, restoring cytoprotective prostaglandin systems, and recovering leaky-gut syndrome pathways.
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva)
Current Pharmaceutical Design
Comprehensive review of BPC 157 clinical development for inflammatory bowel disease including ulcerative colitis trials, demonstrating mucosal healing and anti-inflammatory effects across multiple organ systems.
From the Lab
Related Blog Posts
From the Lab
Related Blog Posts
BPC-157 CAPSULES FAQ
Where do I buy BPC 157 capsules?
Blank Peptides stocks BPC-157 capsules in bottles of 30 at 500mcg per capsule. Same peptide, same cGMP labs and same testing as our injectable vials, just in an oral research format. No prescription is involved. Orders are processed within 1 business day and ship from inside the USA in unmarked outer packaging.
What is in a BPC-157 capsule?
Each capsule holds 500mcg of BPC-157 in a stabilised powder blend, sealed in a standard gelatin shell. Thirty capsules per bottle. Oral BPC-157 appears in the literature because the sequence was originally isolated from gastric juice, and several rodent studies looked at whether it survives the gastric environment intact. That question is exactly what oral research formats are used to investigate.
Are BPC-157 capsules third-party tested?
Yes. The peptide going into the capsules is assayed by HPLC and mass spectrometry in house, then confirmed independently by Freedom Diagnostics or Horizon Analytical, with bacterial endotoxin testing on the batch. Purity is greater than 99%. The linked COA carries the lot number printed on your bottle, so the paperwork and the product line up.
BPC-157 capsules vs injectable BPC-157: which do researchers use?
It depends entirely on the question being asked. Studies looking at systemic exposure or connective tissue models generally use the reconstituted vial, since injectable BPC-157 bypasses first-pass metabolism. Work on gut-local signalling, gastric tolerance or oral bioavailability needs the capsule. Some protocols run both arms side by side to compare.
Do BPC-157 capsules need to be reconstituted?
No. That is the practical difference between the two formats. Capsules arrive ready for oral research protocols, so there is no bacteriostatic water, no swirling and no sterile technique to worry about. If your work calls for a solution rather than a solid dose form, the lyophilized vials are the right SKU.
How should BPC-157 capsules be stored?
Room temperature is fine, but a cool dry cupboard is better. Keep the bottle sealed with the desiccant inside and away from direct light. Humidity is the real enemy with capsules; a bathroom shelf will soften the shells over time. Refrigeration is not necessary and can introduce condensation each time the bottle is opened.
How many capsules come in a bottle and how long does an order take?
Thirty capsules at 500mcg each, 15mg of peptide per bottle. Processing time is within 1 business day, with tracking emailed as soon as the label prints. Multi-bottle pricing is shown in the pack options. Packaging carries no compound names on the outside.
Are BPC-157 capsules a supplement?
No. They are a research chemical in an oral dose format, not a dietary supplement, drug or food product, and they carry no FDA approval. Nothing about the capsule format implies human consumption. Buying them means you are handling them in a laboratory setting under your own institutional or professional judgement.